In 2024, the FDA approved at-home blood and stool tests for colorectal cancer screenings. In October, a second iteration of the at-home stool test was approved.
GI & Endoscopy
From 2004 to 2022, the number of women in the active physician workforce increased 97%, while the number of men increased 13%.
Here are five major GI companies to keep an eye on in 2025:
Here are five gastroenterologists making headlines in their field:
Chicago-based GI Partners of Illinois has partnered with Nashville, Tenn.-based Sylvan Health, a nutritional services provider, on an innovative collaboration unlike any other in the state.
Advertisement
As colorectal cancer rates continue to rise nationwide, even among young patients, surgeons, celebrities and advocacy groups alike are going to new lengths to encourage people to get screened.
A Louisiana-based surgeon is being investigated following multiple allegations of sexual assault from female patients, according to a Jan. 9 report from ABC affiliate KPLC.
U.S. Surgeon General Vivek Murthy, MD, released a new warning at the beginning of January tying several types of cancer, including colorectal cancer, to alcohol consumption.
From prior authorization burdens to the advent of new AI, three gastroenterology specialists spoke with Becker's about the key factors that will make or break the field of GI in 2025.
As all physicians are heading into 2025 battling nationwide shortages and ongoing reimbursement cuts, here are five numbers that are scaring gastroenterologists right now: